Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer ACP Haplotyper VCMap
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:wedelolactone
go back to main search page
Accession:CHEBI:10037 term browser browse the term
Definition:A member of the class of coumestans that is coumestan with hydroxy substituents as positions 1, 8 and 9 and a methoxy substituent at position 3.
Synonyms:exact_synonym: 1,8,9-trihydroxy-3-methoxy-6H-[1]benzofuro[3,2-c]chromen-6-one
 related_synonym: 1,8,9-trihydroxy-3-methoxycoumestan;   Formula=C16H10O7;   InChI=1S/C16H10O7/c1-21-6-2-10(19)14-12(3-6)23-16(20)13-7-4-8(17)9(18)5-11(7)22-15(13)14/h2-5,17-19H,1H3;   InChIKey=XQDCKJKKMFWXGB-UHFFFAOYSA-N;   SMILES=COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21
 xref: CAS:524-12-9;   KEGG:C10541;   KNApSAcK:C00002585;   LIPID_MAPS_instance:LMPK12090046
 xref_mesh: MESH:C051122
 xref: PMID:21315506;   PMID:21463376;   PMID:22198514;   PMID:22204306;   PMID:23076676;   PMID:23141142;   Reaxys:332398;   Wikipedia:Wedelolactone


show annotations for term's descendants           Sort by:
 
wedelolactone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Casp3 caspase 3 multiple interactions EXP wedelolactone inhibits the reaction [Methamphetamine results in increased cleavage of and results in increased activity of CASP3 protein]; wedelolactone inhibits the reaction [Quinolinic Acid results in increased activity of CASP3 protein] CTD PMID:25631491 PMID:29981346 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp4 caspase 4 decreases expression EXP wedelolactone results in decreased expression of CASP4 protein alternative form CTD PMID:25631491 NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092 		JBrowse link
G Cat catalase multiple interactions ISO CAT protein inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein] CTD PMID:22733624 NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Chuk component of inhibitor of nuclear factor kappa B kinase complex multiple interactions EXP wedelolactone inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein] CTD PMID:22207076 NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065 		JBrowse link
G Ednrb endothelin receptor type B multiple interactions EXP wedelolactone inhibits the reaction [Dimethyl Sulfoxide results in increased expression of EDNRB mRNA]; wedelolactone inhibits the reaction [Dimethyl Sulfoxide results in increased expression of EDNRB protein]; wedelolactone inhibits the reaction [Particulate Matter results in increased expression of EDNRB mRNA]; wedelolactone inhibits the reaction [Particulate Matter results in increased expression of EDNRB protein]; wedelolactone inhibits the reaction [Smoke results in increased expression of EDNRB protein]; wedelolactone inhibits the reaction [TNF protein results in increased expression of EDNRB mRNA]; wedelolactone inhibits the reaction [TNF protein results in increased expression of EDNRB protein] CTD PMID:18718921 PMID:20561571 PMID:22207076 NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115 		JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta multiple interactions
decreases activity		 ISO [wedelolactone results in decreased activity of IKBKB protein] which results in decreased phosphorylation of NFKBIA protein CTD PMID:25450232 NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250 		JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP wedelolactone inhibits the reaction [Quinolinic Acid results in increased expression of IL1B protein] CTD PMID:29981346 NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO
EXP		 wedelolactone inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]
wedelolactone inhibits the reaction [Quinolinic Acid results in increased expression of IL6 protein]		 CTD PMID:27793764 PMID:29981346 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO wedelolactone inhibits the reaction [[Cisplatin co-treated with TNF protein] results in increased phosphorylation of JUN protein] CTD PMID:23103562 NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions EXP
ISO		 wedelolactone inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]
[wedelolactone results in decreased activity of IKBKB protein] which results in decreased phosphorylation of NFKBIA protein		 CTD PMID:22207076 PMID:25450232 NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions
increases cleavage		 EXP
ISO		 wedelolactone inhibits the reaction [Methamphetamine results in increased cleavage of PARP1 protein]
wedelolactone results in increased cleavage of PARP1 protein
Acetylcysteine inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein]; Buthionine Sulfoximine promotes the reaction [wedelolactone results in increased cleavage of PARP1 protein]; CAT protein inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein]; S-ethyl glutathione inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein]		 CTD PMID:22733624 PMID:25631491 NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO wedelolactone inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] CTD PMID:27793764 NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions EXP
ISO		 wedelolactone inhibits the reaction [TNF protein results in increased expression of RELA protein]
wedelolactone affects the localization of and results in decreased activity of RELA protein; wedelolactone inhibits the reaction [Palmitic Acid affects the localization of and results in increased activity of RELA protein]		 CTD PMID:22207076 PMID:26422990 NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484 		JBrowse link
G Sele selectin E multiple interactions ISO wedelolactone inhibits the reaction [Palmitic Acid results in increased expression of SELE mRNA] CTD PMID:26422990 NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741 		JBrowse link
G Slc22a6 solute carrier family 22 member 6 multiple interactions
decreases activity		 ISO [wedelolactone results in decreased activity of SLC22A6 protein] which results in increased susceptibility to and results in increased activity of aristolochic acid I CTD PMID:32159797 NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 multiple interactions
decreases activity		 ISO [wedelolactone results in decreased activity of SLC22A8 protein] which results in increased susceptibility to and results in increased activity of aristolochic acid I CTD PMID:32159797 NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450 		JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP
ISO		 wedelolactone inhibits the reaction [TNF protein results in increased expression of EDNRB mRNA]; wedelolactone inhibits the reaction [TNF protein results in increased expression of EDNRB protein]; wedelolactone inhibits the reaction [TNF protein results in increased expression of RELA protein]; wedelolactone inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein]; wedelolactone inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]
wedelolactone inhibits the reaction [TNF protein results in increased abundance of Dinoprostone]; wedelolactone inhibits the reaction [TNF protein results in increased abundance of Thromboxane B2]; wedelolactone inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; wedelolactone inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]
wedelolactone inhibits the reaction [[Cisplatin co-treated with TNF protein] results in increased phosphorylation of JUN protein]		 CTD PMID:22207076 PMID:23103562 PMID:27793764 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO wedelolactone inhibits the reaction [Palmitic Acid results in increased expression of VCAM1 mRNA] CTD PMID:26422990 NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19800
    role 19751
      biological role 19751
        biochemical role 19368
          metabolite 19344
            wedelolactone 18
Path 2
Term Annotations click to browse term
  CHEBI ontology 19800
    subatomic particle 19799
      composite particle 19799
        hadron 19799
          baryon 19799
            nucleon 19799
              atomic nucleus 19799
                atom 19799
                  main group element atom 19698
                    p-block element atom 19698
                      carbon group element atom 19619
                        carbon atom 19609
                          organic molecular entity 19609
                            organic group 18718
                              organic divalent group 18702
                                organodiyl group 18702
                                  carbonyl group 18651
                                    carbonyl compound 18651
                                      carboxylic ester 15883
                                        lactone 11257
                                          delta-lactone 3886
                                            coumestan 1780
                                              wedelolactone 18
paths to the root